SilkTech Biopharmaceuticals

0 followers


SilkTech Biopharmaceuticals develops silk-based anti-inflammatory therapies. Their lead indication is Dry Eye Disease, an inflammatory-based chronic condition.

Industries

Employees

11-50

Links

Org chart

Brian Lawrence
Chief Executive Officer

Brian Lawrence

Collapse
David Infanger
VP, Research & Development
Eric D. Donnenfeld
Founding Partner Of Ophthalmic Consultants Of Connecticut
Richard L. Lindstrom
Founding Partner Of Minnesota Eye Consultants
Edward Holland
Director Of Cornea Services At Cincinnati Eye Institute